Loading organizations...
§ Venture Capital · Vancouver, BC, Canada
A fund dedicated to supporting research, development, and programs within the field of global health sciences.
Global Health Sciences Fund is a venture capital investment vehicle focused on financing biotechnology, medical device, and emerging health technology companies, operating primarily out of Vancouver, British Columbia. The organization operates as a joint venture managed by life sciences investment firm Quark Venture alongside the Chinese investment bank GF Securities. The entity manages a dedicated capital pool with approximately $500 million in assets under management to deploy across early and growth stage healthcare enterprises globally. The firm provides critical financial backing to clinical stage research and commercialization efforts. The fund's investment portfolio includes equity stakes in recognizable life sciences organizations such as SQZ Biotech, Microbion Corporation, Sitka Biopharma, and Elo Life Systems. Global Health Sciences Fund was established in 2016 through the collaborative efforts of founding partners Karimah Es Sabar and the leadership team at GF Securities.
Global Health Sciences Fund has 2 tracked investments across 2 companies. The latest tracked deal is $25.0M Series C in EyeYon in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2021 | EyeYon | $25.0M Series C | CR CP Life Science Fund | Brighton Park Capital, Diamond BioFund, Pontifax, Rimonci Capital, Triventures |
| Jan 1, 2019 | Keros Therapeutics | $23.0M Series B | — | Pontifax Venture Capital, Arkin BIO Ventures, Medison Pharma, Partners Innovation Fund |